| Date Filed | Type | Description |
| 07/08/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0% stake in WW INTERNATIONAL, INC. |
| 05/10/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0% stake in Tivity Health, Inc. |
| 02/14/2022 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 5.9% stake in WW INTERNATIONAL, INC. |
| 02/14/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.4% stake in Tivity Health, Inc. |
| 02/14/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 4.5% stake in GTY Technology Holdings Inc. |
| 10/12/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 1.7% stake in Ziopharm Oncology, Inc. |
| 10/12/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 2% stake in Quotient Technology Inc. |
| 05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.5% stake in Flexion Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 3.8% stake in Precigen, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.4% stake in Ziopharm Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 6.2% stake in Tivity Health, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.1% stake in Quotient Technology Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0.3% stake in Medifast, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.9% stake in Ziopharm Oncology, Inc. |
| 02/14/2020 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 8% stake in Tivity Health, Inc. |
| 02/14/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.4% stake in Quotient Technology Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 8% stake in Medifast, Inc. |
| 02/14/2020 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 5.2% stake in Intrexon Corporation |
| 02/14/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.5% stake in GTY Technology Holdings Inc. |
| 02/14/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 12.9% stake in Flexion Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 6.9% stake in Endo International plc |
| 02/13/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 2.4% stake in Avon Products, Inc. |
| 09/30/2019 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 6% stake in GTY Technology Holdings Inc. |
| 07/17/2019 |
SC 13D
| MILLER VALUE PARTNERS, LLC reports a 6.9% stake in Wright Investors'' Service Holdings, Inc. |
| 04/23/2019 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 10.8% stake in Flexion Therapeutics, Inc. |
| 03/11/2019 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 5% stake in GTY Technology Holdings Inc. |
| 02/14/2019 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 5.7% stake in Ziopharm Oncology, Inc. |
| 02/14/2019 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 5.9% stake in Quotient Technology Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|